269 related articles for article (PubMed ID: 17283585)
1. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.
Tse KC; Lam MF; Tang SC; Tang CS; Chan TM
Lupus; 2007; 16(1):46-51. PubMed ID: 17283585
[TBL] [Abstract][Full Text] [Related]
2. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
Yap DY; Yu X; Chen XM; Lu F; Chen N; Li XW; Tang CS; Chan TM
Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
[TBL] [Abstract][Full Text] [Related]
3. Long-term data on tacrolimus treatment in lupus nephritis.
Yap DY; Ma MK; Mok MM; Kwan LP; Chan GC; Chan TM
Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria.
Tse KC; Li FK; Tang S; Tang CS; Lai KN; Chan TM
Lupus; 2005; 14(12):947-52. PubMed ID: 16425574
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
6. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N
Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
[TBL] [Abstract][Full Text] [Related]
9. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
F L; Y T; X P; L W; H W; Z S; H Z; Z H;
Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
Uchino A; Tsukamoto H; Nakashima H; Yoshizawa S; Furugo I; Mitoma H; Oryoji K; Shimoda T; Niiro H; Tada Y; Yano T; Nonaka T; Oishi R; Akashi K; Horiuchi T
Clin Exp Rheumatol; 2010; 28(1):6-12. PubMed ID: 20346231
[TBL] [Abstract][Full Text] [Related]
11. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
Fei Y; Wu Q; Zhang W; Chen H; Hou Y; Xu D; Li M; Zhang X; Zhao Y; Zeng X; Zhang F
Clin Exp Rheumatol; 2013; 31(1):62-8. PubMed ID: 22935463
[TBL] [Abstract][Full Text] [Related]
12. Good response of membranous lupus nephritis to tacrolimus.
Maruyama M; Yamasaki Y; Sada K; Sarai A; Ujike K; Maeshima Y; Nakamura Y; Sugiyama H; Makino H
Clin Nephrol; 2006 Apr; 65(4):276-9. PubMed ID: 16629227
[TBL] [Abstract][Full Text] [Related]
13. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
[TBL] [Abstract][Full Text] [Related]
15. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
Mok CC; To CH; Yu KL; Ho LY
Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.
Cortés-Hernández J; Torres-Salido MT; Medrano AS; Tarrés MV; Ordi-Ros J
Nephrol Dial Transplant; 2010 Dec; 25(12):3939-48. PubMed ID: 20538787
[TBL] [Abstract][Full Text] [Related]
17. Success using tacrolimus in patients with proliferative and membranous lupus nephritis and refractory proteinuria.
Gordon S; Denunzio T; Uy A
Hawaii J Med Public Health; 2013 Sep; 72(9 Suppl 4):18-23. PubMed ID: 24052913
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
Ikeuchi H; Hiromura K; Takahashi S; Mishima K; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Kuroiwa T; Nojima Y
Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
[TBL] [Abstract][Full Text] [Related]
20. Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy.
Kanda H; Kubo K; Tateishi S; Sato K; Yonezumi A; Yamamoto K; Mimura T
Lupus; 2005; 14(4):288-92. PubMed ID: 15864915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
